Literature DB >> 15074747

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis.

H Lukka, M Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15074747     DOI： 10.1016/j.clon.2004.01.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  4 in total

1.  Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response.

Authors:  Alpana Sharma; Medha Rajappa; Abhigyan Satyam; Manoj Sharma
Journal:  Mol Cell Biochem       Date:  2010-03-31       Impact factor: 3.396

2.  MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.

Authors:  Hui Yang; Xiao-Li Wu; Kai-Hua Wu; Rong Zhang; Li-Li Ju; Ying Ji; Yan-Wei Zhang; Song-Lin Xue; Ye-Xin Zhang; Yong-Feng Yang; Min-Min Yu
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

3.  MicroRNA-138 inhibits tumor growth and enhances chemosensitivity in human cervical cancer by targeting H2AX.

Authors:  Min Yuan; Shuting Zhao; Rui Chen; Guozeng Wang; Yachun Bie; Qianyu Wu; Jingxin Cheng
Journal:  Exp Ther Med       Date:  2019-11-22       Impact factor: 2.447

4.  Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.

Authors:  Jina Li; Gaoming Liu; Jiayou Luo; Shipeng Yan; Ping Ye; Jie Wang; Miyang Luo
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.